These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 36524397)

  • 1. Potential implications of polyphenolic compounds in neurodegenerative diseases.
    Shi R; Gao D; Stoika R; Liu K; Sik A; Jin M
    Crit Rev Food Sci Nutr; 2024; 64(16):5491-5514. PubMed ID: 36524397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurodegenerative Diseases and Flavonoids: Special Reference to Kaempferol.
    Rahul ; Siddique YH
    CNS Neurol Disord Drug Targets; 2021; 20(4):327-342. PubMed ID: 33511932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Icariin: A Potential Neuroprotective Agent in Alzheimer's Disease and Parkinson's Disease.
    Khezri MR; Ghasemnejad-Berenji M
    Neurochem Res; 2022 Oct; 47(10):2954-2962. PubMed ID: 35802286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyphenols and Their Impact on the Prevention of Neurodegenerative Diseases and Development.
    Grabska-Kobyłecka I; Szpakowski P; Król A; Książek-Winiarek D; Kobyłecki A; Głąbiński A; Nowak D
    Nutrients; 2023 Aug; 15(15):. PubMed ID: 37571391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Review on the neuroprotective effects of green tea polyphenols for the treatment of neurodegenerative diseases].
    Li Q; Li Y
    Wei Sheng Yan Jiu; 2010 Jan; 39(1):123-6. PubMed ID: 20364607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary Plant Polyphenols as the Potential Drugs in Neurodegenerative Diseases: Current Evidence, Advances, and Opportunities.
    Yan L; Guo MS; Zhang Y; Yu L; Wu JM; Tang Y; Ai W; Zhu FD; Law BY; Chen Q; Yu CL; Wong VK; Li H; Li M; Zhou XG; Qin DL; Wu AG
    Oxid Med Cell Longev; 2022; 2022():5288698. PubMed ID: 35237381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring promising minor natural phenolic compounds in neuroprotection-related preclinical models.
    Moreira Vasconcelos CF; Neugebauer AZ; Basto Souza R
    Basic Clin Pharmacol Toxicol; 2024 Jun; 134(6):770-777. PubMed ID: 38566316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Inflammatory Effects of Flavonoids in Common Neurological Disorders Associated with Aging.
    Martínez-Coria H; Arrieta-Cruz I; Gutiérrez-Juárez R; López-Valdés HE
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical utility of neuroprotective agents in neurodegenerative diseases: current status of drug development for Alzheimer's, Parkinson's and Huntington's diseases, and amyotrophic lateral sclerosis.
    Dunkel P; Chai CL; Sperlágh B; Huleatt PB; Mátyus P
    Expert Opin Investig Drugs; 2012 Sep; 21(9):1267-308. PubMed ID: 22741814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New therapeutic strategy for Parkinson's and Alzheimer's disease.
    Esposito E; Cuzzocrea S
    Curr Med Chem; 2010; 17(25):2764-74. PubMed ID: 20586718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naringenin: A prospective therapeutic agent for Alzheimer's and Parkinson's disease.
    Goyal A; Verma A; Dubey N; Raghav J; Agrawal A
    J Food Biochem; 2022 Dec; 46(12):e14415. PubMed ID: 36106706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective role of polyphenols against oxidative stress-mediated neurodegeneration.
    Uddin MS; Al Mamun A; Kabir MT; Ahmad J; Jeandet P; Sarwar MS; Ashraf GM; Aleya L
    Eur J Pharmacol; 2020 Nov; 886():173412. PubMed ID: 32771668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms of the neuroprotective/neurorescue action of multi-target green tea polyphenols.
    Mandel SA; Weinreb O; Amit T; Youdim MB
    Front Biosci (Schol Ed); 2012 Jan; 4(2):581-98. PubMed ID: 22202078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefits under the Sea: The Role of Marine Compounds in Neurodegenerative Disorders.
    Catanesi M; Caioni G; Castelli V; Benedetti E; d'Angelo M; Cimini A
    Mar Drugs; 2021 Jan; 19(1):. PubMed ID: 33430021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural Products for the Treatment of Neurodegenerative Diseases.
    Wang Z; He C; Shi JS
    Curr Med Chem; 2020; 27(34):5790-5828. PubMed ID: 31131744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanomedicine for Neurodegenerative Disorders: Focus on Alzheimer's and Parkinson's Diseases.
    Jagaran K; Singh M
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Pharmacological Appraisal of Neuroprotective and Neurorestorative Flavonoids Against Neurodegenerative Diseases.
    Zhao J; Zhu M; Kumar M; Ngo FY; Li Y; Lao L; Rong J
    CNS Neurol Disord Drug Targets; 2019; 18(2):103-114. PubMed ID: 30394219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Bioactives in Neurodegenerative Diseases.
    Zacharia LC
    Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurological mechanisms of green tea polyphenols in Alzheimer's and Parkinson's diseases.
    Weinreb O; Mandel S; Amit T; Youdim MB
    J Nutr Biochem; 2004 Sep; 15(9):506-16. PubMed ID: 15350981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Putative Roles of Plant-Derived Tannins in Neurodegenerative and Neuropsychiatry Disorders: An Updated Review.
    Hussain G; Huang J; Rasul A; Anwar H; Imran A; Maqbool J; Razzaq A; Aziz N; Makhdoom EUH; Konuk M; Sun T
    Molecules; 2019 Jun; 24(12):. PubMed ID: 31200495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.